Lansoprazole Tablet, Orally Disintegrating
Product Images NDC 68382-772
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68382-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lansoprazole Delayed-release Orally Disintegrating Tablets (3de4f129 Dc87 48e1 B934 B2a038df8cf7 02)
Lansoprazole Delayed-release Orally Disintegrating Tablets (3de4f129 Dc87 48e1 B934 B2a038df8cf7 03)
Lansoprazole Delayed-release Orally Disintegrating Tablets, 15 mg (3de4f129 Dc87 48e1 B934 B2a038df8cf7 04)
Lansoprazole Delayed-release Orally Disintegrating Tablets, 30 mg (3de4f129 Dc87 48e1 B934 B2a038df8cf7 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.